Epithelial-mesenchymal transition in cervical carcinoma

Area of Science:

• Oncology
• Cell Biology
• Molecular Biology

Background:

• Cervical cancer, a common female malignancy, often recurs or metastasizes despite early-stage treatment.
• Epithelial-mesenchymal transition (EMT) is a key process implicated in tumor metastasis and recurrence.
• Understanding EMT mechanisms in cervical cancer is crucial for developing targeted therapies.

Purpose of the Study:

• To provide an up-to-date overview of the epithelial-mesenchymal transition (EMT) program in cervical cancer.
• To summarize molecules and pathways involved in EMT-driven cervical cancer metastasis.
• To highlight key regulatory factors, including transcription factors and tumor suppressors.

Main Methods:

• Literature review of studies on EMT in cervical cancer.
• Analysis of molecular mechanisms, signaling pathways, and regulatory factors involved in EMT.
• Summary of the role of human papilloma viral proteins in cervical cancer progression.

Main Results:

• Human papilloma viral proteins contribute to cell transformation and hybrid epithelial-mesenchymal phenotypes.
• Soluble factors, ion transport systems, and cytoskeletal modulators stimulate EMT in cervical cancer cells.
• Transcription factors like Snail, Twist1, Twist2, and Six1 are central to regulating EMT and metastasis, with Snail being a key regulator.

Conclusions:

• EMT is a critical process in cervical cancer metastasis, regulated by various molecular players.
• Snail acts as a central transcription factor governing the EMT program in cervical cancer.
• Tumor suppressors such as SFRP1/2 and LMX-1A can inhibit EMT, potentially suppressing cervical cancer progression and metastasis.